Pharmaceutical formulations for the sustained release of active ingredient(s), as well as their applications, especially therapeutic

Details for Australian Patent Application No. 2007255367 (hide)

Owner Flamel Technologies

Inventors Bonnet Gonnet, Cecile; Soula, Olivier; Constancis, Alain; Chognot, David

Agent Spruson & Ferguson

Pub. Number AU-B-2007255367

PCT Pub. Number WO2007/141344

Priority 06/05152 09.06.06 FR

Filing date 11 June 2007

Wipo publication date 13 December 2007

Acceptance publication date 2 August 2012

International Classifications

A61K 9/00 Medicinal preparations characterised by special physical form

A61K 9/10 Medicinal preparations characterised by special physical form - Dispersions

A61K 9/16 Medicinal preparations characterised by special physical form - Agglomerates

A61K 9/19 Medicinal preparations characterised by special physical form - lyophilised

A61K 38/21 Medicinal preparations containing peptides - Interferons

A61K 38/27 Medicinal preparations containing peptides - Growth hormone (GH) (Somatotropin)

A61K 38/28 Medicinal preparations containing peptides - Insulins

Event Publications

8 January 2009 PCT application entered the National Phase

  PCT publication WO2007/141344 Priority application(s): WO2007/141344

2 August 2012 Application Accepted

  Published as AU-B-2007255367

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007255381-Composites of inorganic and/or organic microparticles and nano-dolomite particles

2007255366-Phenyl pyrrole aminoguanidine derivatives